Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with ...
Duke-NUS, the only graduate-entry medical school in Singapore, has joined the US based TriNetX global research netw...
The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...
CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...
Belgium based Europital, the global provider of medical management services for clinical research and drug dev...
Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the ‘2020 Frost & Su...
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first p...
The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal, announced that...
A Two-part Phase I Study With the Antibody-drug Conjugate SYD985 in Combination With Niraparib to Evaluate Safety, Pharm...
AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biopharmaceutical company aiming to democratize R&D ...
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Av...
BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivot...
